Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Innate-like T cells: A promising asset in anti-cancer immunity

Cancer Cell(2022)10.1016/j.ccell.2022.05.017Source: DataRank Database

Innate-like T cells: A promising asset in anti-cancer immunity is a research paper published in Cancer Cell (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.84)OA: greenTopics (30)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Marco Colonna ORCID,Martina Molgora ORCID

Live enrichment

PubMed:35714605 PMC:PMC9359000 OpenAlex:https://openalex.org/W4282964103

National Institutes of Health

Grant: R01 CA262684

National Institutes of Health

Grant: 5R01CA262684-02

Targeting TREM2 to boost anti-cancer therapy

NGM Biopharmaceuticals

Institute of Cancer Research

FWCI

0.84

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

greenLicense: Elsevier Non-Commercial

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9359000

publisherhttps://api.elsevier.com/content/article/PII:S1535610822002306?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610822002306?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2022.05.017

Fields of Study

CAR-T cell therapy researchImmune Cell Function and InteractionCancer Immunotherapy and Biomarkers0301 basic medicine0303 health sciences03 medical and health sciencesHumansImmunity, InnateNeoplasmsT-Lymphocytes

MeSH Terms

HumansImmunity, InnateNeoplasmsT-Lymphocytes

Keywords

Innate immune systemCytotoxic T cellBiologyCancerImmunologyInnate lymphoid cellImmunityCancer cellCancer researchImmune systemIn vitroGeneticsNeoplasmsT-LymphocytesHumansImmunity, Innate

Sustainable Development Goals

SDG 0: Good health and well-being